NPPA seeks clarification on Gilead’s drug pricing plea

NEW DELHI: India’s drug pricing regulator has raised a red flag against price exemption plea made by US drug maker Gilead Sciences for its medicine for treatment of chronic Hepatitis B, revealed NPPA in its minutes of the meeting. Observing that the submission by Gilead was also tantamount to ever greening, which would mean a… Continue reading NPPA seeks clarification on Gilead’s drug pricing plea

SCHOTT increases sales in India and plans record investments

Germany headquartered SCHOTT AG, international specialty glass and technical ceramic materials manufacturer, has continued on its growth course in fiscal year 2018/19 (October 1, 2018, to September 30, 2019). Its key financial figures developed positively or remained at a solid level from previous year. “We are pleased with the past fiscal year. We were able… Continue reading SCHOTT increases sales in India and plans record investments

Christopher Rudolf: Defining New Ways to Diagnose Diseases and Help Patients

The reality of healthcare data is that it is messy, sparse and varies in structure enormously between different systems, countries and languages. Over the last ten years, the Volv team has developed original and innovative mathematics to allow the company to be able to derive value from this data unchanged. Volv Global provides applied data… Continue reading Christopher Rudolf: Defining New Ways to Diagnose Diseases and Help Patients

Guha on ‘harmoniser’ Gandhi, Lavasa calls India’s first elections ‘fateful experiment’

File photo of Mahatma Gandhi | Central Press/Getty Images Text Size: Great harmoniser of India’s diversity Ramachandra Guha| Historian and author of ‘Gandhi: The Years that Changed the World 1914-1948’ Hindustan Times Guha states that when Gandhi came back from South Africa he initially stayed at the house of S.K. Rudra, Principal of St. Stephen’s… Continue reading Guha on ‘harmoniser’ Gandhi, Lavasa calls India’s first elections ‘fateful experiment’

Budget 2020: Current health concerns warrant greater budgetary backing for innovation and …

Greater investment in biological sciences is crucial because we are in times when both non-communicable diseases (like cancer and diabetes) and infectious diseases (caused by new viruses) are only going to riseKiran Mazumdar-Shaw        Last Updated: January 31, 2020  | 00:32 IST There is much to hope for from this Budget, especially for the Indian healthcare sector. Take… Continue reading Budget 2020: Current health concerns warrant greater budgetary backing for innovation and …

Strides Pharma Science Q3 net declines 69% to Rs 92 crore

The consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.PTI|Last Updated: Jan 30, 2020, 01.06 PM ISTGetty ImagesThe company had posted consolidated profit of Rs 296.43 crore in the year-ago period, Strides Pharma Science said in a regulatory filing. Drug firm Strides Pharma Science on Thursday posted 68.8 per cent… Continue reading Strides Pharma Science Q3 net declines 69% to Rs 92 crore

D-Street Buzz: Pharma stocks tumble, Aurobindo Pharma falls 4%; YES Bank, Zee Ent drag

The Indian equity market has been jilted by the outbreak of the coronavirus in China spooking investors fearing that the virus outbreak may derail the pace of economic growth.The market sentiment is nervous with Sensex down 221.90 points or 0.54 percent at 40976.76 while the Nifty shed 66.50 points at 12063.All sectoral indices are trading in the red led by… Continue reading D-Street Buzz: Pharma stocks tumble, Aurobindo Pharma falls 4%; YES Bank, Zee Ent drag

USFDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action

The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues. Representative image Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing facility may be subject to regulatory actions.The company stressed that it will… Continue reading USFDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action

Cipla sets up chemistry research lab at IISER Pune

The lab aims to provide practical training in Chemistry to undergraduates and researchers Cipla Foundation, the social responsibility arm of Cipla Ltd, has funded the set-up of a chemistry research laboratory at the Indian Institute of Science Education and Research (IISER) Pune. The lab aims to provide practical training in Chemistry to undergraduates and researchers… Continue reading Cipla sets up chemistry research lab at IISER Pune